AAAAAA

   
Results: 1-22 |
Results: 22
Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention
Authors: Sdringola, S Assali, AR Ghani, M Moustapha, A Achour, H Yusuf, SW Fujise, K Rosales, O Schroth, GW Anderson, HV Smalling, RW
Citation: S. Sdringola et al., Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention, CATHET C IN, 54(3), 2001, pp. 318-324
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes - A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
Authors: Cannon, CP Battler, A Brindis, RG Cox, JL Ellis, SG Every, NR Flaherty, JT Harrington, RA Krumholz, HM Simoons, ML Van de Werf, FJJ Weintraub, WS Mitchell, KR Morrisson, SL Brandis, RG Anderson, HV Cannom, DS Chitwood, WR Cigarroa, JE Collins-Nakai, RL Ellis, SG Gibbons, RJ Grover, FL Heidenreich, PA Khandheria, BK Knoebel, SB Krumholz, HL Malenka, DJ Mark, DB McKay, CR Passamani, ER Radford, MJ Riner, RN Schwartz, JB Shaw, RE Shemin, RJ Van Fossen, DB Verrier, ED Watkins, MW Phoubandith, DR Furnelli, T
Citation: Cp. Cannon et al., American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes - A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee), J AM COL C, 38(7), 2001, pp. 2114-2130
Percutaneous and surgical interventions for in-stent restenosis: Long-termoutcomes and effect of diabetes mellitus
Authors: Moustapha, A Assali, AR Sdringola, S Vaughn, WK Fish, RD Rosales, O Schroth, G Krajcer, Z Smalling, RW Anderson, HV
Citation: A. Moustapha et al., Percutaneous and surgical interventions for in-stent restenosis: Long-termoutcomes and effect of diabetes mellitus, J AM COL C, 37(7), 2001, pp. 1877-1882
Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries
Authors: Anderson, HV McNatt, J Clubb, FJ Herman, M Maffrand, JP DeClerck, F Ahn, C Buja, LM Willerson, JT
Citation: Hv. Anderson et al., Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries, CIRCULATION, 104(19), 2001, pp. 2331-2337
Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab ortirofiban)
Authors: Assali, AR Salloum, J Sdringola, S Moustapha, A Ghani, M Hale, S Schroth, G Fujise, K Anderson, HV Smalling, RW Rosales, OR
Citation: Ar. Assali et al., Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab ortirofiban), AM J CARD, 88(8), 2001, pp. 884
Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon
Authors: Sdringola, S Assali, A Ghani, M Yepes, A Rosales, O Schroth, GW Fujise, K Anderson, HV Smalling, RW
Citation: S. Sdringola et al., Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon, CATHET C IN, 51(4), 2000, pp. 394-399
Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon
Authors: Assali, AR Sdringola, S Ghani, M Denkats, AE Yepes, A Hanna, GP Schroth, G Fujise, K Anderson, HV Smalling, RW Rosales, OR
Citation: Ar. Assali et al., Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon, CATHET C IN, 51(1), 2000, pp. 27-31
Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban
Authors: Assali, AR Sdringola, S Ghani, M Westbrook, LA Anderson, HV Schroth, G Fujise, K Smalling, RW Rosales, OR
Citation: Ar. Assali et al., Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban, J INVAS CAR, 12(9), 2000, pp. 460-463
Platelet GP IIb/IIIa inhibition in myocardial infarction treated by coronary stenting: Ready for prime time
Authors: Anderson, HV
Citation: Hv. Anderson, Platelet GP IIb/IIIa inhibition in myocardial infarction treated by coronary stenting: Ready for prime time, J INVAS CAR, 12(3), 2000, pp. 140-141
Balloon to artery ratio, not inflation pressure, correlates with adequate stent deployment: Size is more important than pressure
Authors: Fujise, K Yhip, PA Anderson, HV Schroth, G Rosales, O Smalling, RW
Citation: K. Fujise et al., Balloon to artery ratio, not inflation pressure, correlates with adequate stent deployment: Size is more important than pressure, J INTERV CA, 13(4), 2000, pp. 223-229
One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies inunstable angina and non-Q wave myocardial infarction (vol 26, pg 1643, 1995)
Authors: Anderson, HV Cannon, CP Stone, PH
Citation: Hv. Anderson et al., One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies inunstable angina and non-Q wave myocardial infarction (vol 26, pg 1643, 1995), J AM COL C, 35(1), 2000, pp. 263-263
Revascularization interventions for ischemic heart disease
Authors: Moustapha, A Anderson, HV
Citation: A. Moustapha et Hv. Anderson, Revascularization interventions for ischemic heart disease, CURR OPIN C, 15(6), 2000, pp. 463-471
Provisional versus routine stenting - Routine stenting is here to stay
Authors: Anderson, HV Carabello, BA
Citation: Hv. Anderson et Ba. Carabello, Provisional versus routine stenting - Routine stenting is here to stay, CIRCULATION, 102(24), 2000, pp. 2910-2914
Cocaine-induced pneumopericardium
Authors: Albrecht, CA Jafri, A Linville, L Anderson, HV
Citation: Ca. Albrecht et al., Cocaine-induced pneumopericardium, CIRCULATION, 102(22), 2000, pp. 2792-2794
Coronary artery flow velocity is related to lumen area and regional left ventricular mass
Authors: Anderson, HV Stokes, MJ Leon, M Abu-Halawa, SA Stuart, Y Kirkeeide, RL
Citation: Hv. Anderson et al., Coronary artery flow velocity is related to lumen area and regional left ventricular mass, CIRCULATION, 102(1), 2000, pp. 48-54
Causes of early reintervention after successful coronary artery stenting
Authors: Assali, AR Sdringola, S Ghani, M Moustapha, A Anderson, HV Schroth, G Fujise, K Smalling, RW Rosales, O
Citation: Ar. Assali et al., Causes of early reintervention after successful coronary artery stenting, AM J CARD, 86(9), 2000, pp. 1018-1021
Experimental models useful in evaluating myocardial viability
Authors: Willerson, JT Anderson, HV
Citation: Jt. Willerson et Hv. Anderson, Experimental models useful in evaluating myocardial viability, MYOCARDIAL VIABILITY: A CLINICAL AND SCIENTIFIC TREATISE, 2000, pp. 79-90
Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon
Authors: Hanna, GP Yhip, P Fujise, K Schroth, GW Rosales, OR Anderson, HV Smalling, RW
Citation: Gp. Hanna et al., Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon, CATHET C IN, 48(3), 1999, pp. 275-278
A multicenter, randomized study of argatroban versus heparin as adjunct totissue plasminogen activator (TPA) in acute myocardial infarction: Myocardial infarction with novastan and TPA (MINT) study
Authors: Jang, IK Brown, DFM Giugliano, RP Anderson, HV Losordo, D Nicolau, JC Dutra, OP Bazzino, O Viamonte, VM Norbady, R Liprandi, AS Massey, TJ Dinsmore, R Schwarz, RP
Citation: Ik. Jang et al., A multicenter, randomized study of argatroban versus heparin as adjunct totissue plasminogen activator (TPA) in acute myocardial infarction: Myocardial infarction with novastan and TPA (MINT) study, J AM COL C, 33(7), 1999, pp. 1879-1885
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty
Authors: Blankenship, JC Krucoff, MW Werns, SW Anderson, HV Landau, C White, HJ Green, CL Spokojny, AM Bach, RG Raymond, RE Pinkston, J Rawert, M Talley, JD
Citation: Jc. Blankenship et al., Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty, AM J CARD, 83(5), 1999, pp. 675-680
Estrogen replacement therapy after coronary angioplasty - Reply
Authors: Anderson, HV Vaughn, WK
Citation: Hv. Anderson et Wk. Vaughn, Estrogen replacement therapy after coronary angioplasty - Reply, AM J CARD, 83(3), 1999, pp. 475-475
Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry
Authors: Scirica, BM Moliterno, DJ Every, NR Anderson, HV Aguirre, FV Granger, CB Lambrew, CT Rabbani, LE Sapp, SK Booth, JE Ferguson, JJ Cannon, CP
Citation: Bm. Scirica et al., Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry, AM HEART J, 138(6), 1999, pp. 1065-1072
Risultati: 1-22 |